Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Gold

Showing results (31-40 of 700) with videos related to

Pageof 70
Sort By:
Brain : a Journal of Neurology|June 22, 2002
Devic's disease: bridging the gap between laboratory and clinicRalf Gold, Christopher Linington
Expert Opinion on Pharmacotherapy|November 13, 2013
Review of laquinimod and its therapeutic potential in multiple sclerosisJan Thöne, Ralf Gold
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 25, 2015
Present and Future Therapies in Neuromyelitis Optica Spectrum DisordersIngo Kleiter, Ralf Gold
Nature Reviews. Neurology|November 18, 2017
Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratificationKalliopi Pitarokoili, Ralf Gold
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2016
Anti-JC virus antibody testing for natalizumab-induced progressive multifocal leukoencephalopathy: Where are we and where should we go?Andrew Chan, Ralf Gold
Nature Reviews. Neurology|July 31, 2019
Heterogeneous GBS course requires standardized guidelinesKalliopi Pitarokoili, Ralf Gold
JAMA Neurology|March 9, 2016
Positive Effect on Multiple Sclerosis With Treatment of Metabolic SyndromeAiden Haghikia, Ralf Gold
Current Opinion in Neurology|September 28, 2002
Animal models of immune-mediated neuropathiesMathias Mäurer, Ralf Gold
The Lancet. Neurology|November 23, 2020
High-dose biotin in multiple sclerosis: the end of the roadJeremias Motte, Ralf Gold
Nature Clinical Practice. Neurology|August 26, 2006
Can pathological patterns be used to guide individualized multiple sclerosis therapy?Andrew Chan, Ralf Gold
Pageof 70

Showing results (31-40 of 700) with videos related to

Sort By:
Pageof 70
Brain : a Journal of Neurology|June 22, 2002
Devic's disease: bridging the gap between laboratory and clinicRalf Gold, Christopher Linington
Expert Opinion on Pharmacotherapy|November 13, 2013
Review of laquinimod and its therapeutic potential in multiple sclerosisJan Thöne, Ralf Gold
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 25, 2015
Present and Future Therapies in Neuromyelitis Optica Spectrum DisordersIngo Kleiter, Ralf Gold
Nature Reviews. Neurology|November 18, 2017
Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratificationKalliopi Pitarokoili, Ralf Gold
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2016
Anti-JC virus antibody testing for natalizumab-induced progressive multifocal leukoencephalopathy: Where are we and where should we go?Andrew Chan, Ralf Gold
Nature Reviews. Neurology|July 31, 2019
Heterogeneous GBS course requires standardized guidelinesKalliopi Pitarokoili, Ralf Gold
JAMA Neurology|March 9, 2016
Positive Effect on Multiple Sclerosis With Treatment of Metabolic SyndromeAiden Haghikia, Ralf Gold
Current Opinion in Neurology|September 28, 2002
Animal models of immune-mediated neuropathiesMathias Mäurer, Ralf Gold
The Lancet. Neurology|November 23, 2020
High-dose biotin in multiple sclerosis: the end of the roadJeremias Motte, Ralf Gold
Nature Clinical Practice. Neurology|August 26, 2006
Can pathological patterns be used to guide individualized multiple sclerosis therapy?Andrew Chan, Ralf Gold
Pageof 70